Drug Delivery - FDAnews€¦ · List of companies in this report 3M DDS Abraxis BioScience Access Pharmaceuticals Inc Acrux Ltd Alkermes Inc Apricus Biosciences Aptar Group ... Vivus

World Leaders in Health Industry Analysis

Drug DeliverySurveying the global

competitive landscape

December 2010

Drug Delivery: Surveying the global competitive landscape

December 2010

ISBN: 978-1-85822-412-1

© Copyright 2010 Espicom Business Intelligence

All rights reserved. No part of this publication may be reproduced or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping or storage in information retrieval systems without the express permission of

the publisher.

Every care has been taken to ensure that the information contained in this report is correct. The publisher accepts no liability for decisions made on the basis of information contained herein.

British Library Cataloguing in Publication Data.

A catalogue record for this report is available from the British Library.

©Espicom Business Intelligence December 2010ii

©Espicom Business Intelligence iiiDecember 2010

Drug Delivery: Surveying the global competitive landscape Table of Contents

List of companies in this report3M DDS

Abraxis BioScienceAccess Pharmaceuticals Inc

Acrux LtdAlkermes Inc

Apricus BiosciencesAptar Group

Aradigm CorporationArchimedes Pharma

Baxa CorporationBaxter International Inc

BioDelivery Sciences InternationalBioject Medical Technologies Inc

BioSante Pharmaceuticals IncCalando Pharmaceuticals

Camurus ABCareFusion

Celator PharmaceuticalsCell Therapeutics

CephalonCipher Pharmaceuticals

Columbia Laboratories IncConsort Medical

Cornerstone TherapeuticsCPEX Pharmaceuticals Inc

CyDex Pharmaceuticals Debiopharm

Delcath SystemsDepomed Inc

Durect Corporation DUSA Pharmaceuticals Inc

Echo TherapeuticsElan Corporation

Elite Pharmaceuticals IncEGEN Inc

Emisphere Technologies IncEncap Drug Delivery

Endo PharmaceuticalsEndocyteEnzon Inc

Epeius BiotechnologiesEthypharm S/A

EurandFlamel Technologies Inc

FzioMed IncGenerex Biotechnology Corporation

Gilead SciencesHospira

Ikano Therapeutics IncImmunoGen

Impax Laboratories IncInnocoll Technologies

Inovio PharmaceuticalsInSite Vision Inc

IntelGenxIntercell

KV Pharmaceutical

©Espicom Business Intelligence December 2010iv

Drug Delivery: Surveying the global competitive landscapeTable of Contents

Labopharm IncLavipharm Group

Light Sciences OncologyMannKind Corporation

Marina BiotechMaxCyte Inc

MedImmune IncMilestone Scientific

Moog Medical DevicesNanobiotix

NanoMaterials TechnologyNanoBio Corporation

NanoBioMagneticsNanoCarrier

Nanotherapeutics IncNanoVentures Australia

Nektar Therapeutics NeoPharm IncNeurotech SA

NovaDel Pharma IncNovagali Pharma

Novavax Inc Noven Pharmaceuticals IncOakwood Laboratories LLC

OctoPlusOrexo

Otsuka HoldingsPacira Pharmaceuticals Inc

PCI BiotechPhosphagenics Limited

Photocure ASAPolyTherics

pSividaQLT

Quest PharmaTechRaptor Pharmaceuticals

Retractable TechnologiesSavara Pharmaceuticals

Scolr Pharma Inc Seattle Genetics

Silence TherapeuticsSkinvisible Inc

SkyePharma PLCSoligenix

StarpharmaSupratek Pharma Inc

Tekmira PharmaceuticalsTelesso Technologies

Transdel PharmaceuticalsTransPharma Medical

Urigen PharmaceuticalsValeant Pharmaceuticals

Vectura LtdVical

Vivus IncZogenix

Zosano Pharma

Table of Contents

Contents3M DRUG DELIVERY SYSTEMS ..........................................................................................................................1

KEY PERSONNEL ...............................................................................................................................................................................1COMPANY OVERVIEW .....................................................................................................................................................................1KEY MILESTONES .............................................................................................................................................................................1PRODUCTS / TECHNOLOGIES .........................................................................................................................................................2AGREEMENTS ....................................................................................................................................................................................6KEY FINANCIAL DATA .......................................................................................................................................................................7COMPETITION ...................................................................................................................................................................................7

ABRAXIS BIOSCIENCE INC .................................................................................................................................9KEY PERSONNEL ...............................................................................................................................................................................9COMPANY OVERVIEW .....................................................................................................................................................................9KEY MILESTONES .............................................................................................................................................................................9PRODUCTS / TECHNOLOGIES .......................................................................................................................................................10RESEARCH STRATEGY ....................................................................................................................................................................11AGREEMENTS ..................................................................................................................................................................................13KEY FINANCIAL DATA .....................................................................................................................................................................14

ACCESS PHARMACEUTICALS INC....................................................................................................................15KEY PERSONNEL .............................................................................................................................................................................15COMPANY OVERVIEW ...................................................................................................................................................................15KEY MILESTONES ...........................................................................................................................................................................15PRODUCTS / TECHNOLOGIES .......................................................................................................................................................16RESEARCH ACTIVITIES ...................................................................................................................................................................18AGREEMENTS ..................................................................................................................................................................................20KEY FINANCIAL DATA .....................................................................................................................................................................22COMPETITION .................................................................................................................................................................................22

ACRUX LTD ........................................................................................................................................................23KEY PERSONNEL .............................................................................................................................................................................23COMPANY OVERVIEW ...................................................................................................................................................................23KEY MILESTONES ...........................................................................................................................................................................23PRODUCTS / TECHNOLOGIES .......................................................................................................................................................24RESEARCH ACTIVITIES ...................................................................................................................................................................25AGREEMENTS ..................................................................................................................................................................................26KEY FINANCIAL DATA .....................................................................................................................................................................26

ALKERMES INC..................................................................................................................................................27KEY PERSONNEL .............................................................................................................................................................................27COMPANY OVERVIEW ...................................................................................................................................................................27KEY MILESTONES ...........................................................................................................................................................................27PRODUCTS / TECHNOLOGIES ......................................................................................................................................................28RESEARCH ACTIVITIES ..................................................................................................................................................................30AGREEMENTS ..................................................................................................................................................................................34KEY FINANCIAL DATA .....................................................................................................................................................................34COMPETITION .................................................................................................................................................................................35

APRICUS BIOSCIENCES INC .............................................................................................................................37KEY PERSONNEL .............................................................................................................................................................................37COMPANY OVERVIEW ...................................................................................................................................................................37KEY MILESTONES ...........................................................................................................................................................................37PRODUCTS / TECHNOLOGIES .......................................................................................................................................................38RESEARCH ACTIVITIES ...................................................................................................................................................................39AGREEMENTS ..................................................................................................................................................................................40

©Espicom Business Intelligence vDecember 2010

Drug Delivery: Surveying the global competitive landscape

©Espicom Business Intelligence December 2010vi


KEY FINANCIAL DATA .................................................................................................................................................................... 40COMPETITION ................................................................................................................................................................................ 41

APTARGROUP .................................................................................................................................................. 43KEY PERSONNEL ............................................................................................................................................................................ 43COMPANY OVERVIEW .................................................................................................................................................................. 43KEY MILESTONES .......................................................................................................................................................................... 43PRODUCTS / TECHNOLOGIES ...................................................................................................................................................... 44KEY FINANCIAL DATA .................................................................................................................................................................... 45COMPETITION ................................................................................................................................................................................ 45

ARADIGM CORPORATION ...............................................................................................................................47KEY PERSONNEL ............................................................................................................................................................................ 47COMPANY OVERVIEW .................................................................................................................................................................. 47KEY MILESTONES .......................................................................................................................................................................... 47PRODUCTS / TECHNOLOGIES ...................................................................................................................................................... 48RESEARCH ACTIVITIES .................................................................................................................................................................. 48KEY FINANCIAL DATA .................................................................................................................................................................... 49COMPETITION ................................................................................................................................................................................ 50

ARCHIMEDES PHARMA ...................................................................................................................................51KEY PERSONNEL ............................................................................................................................................................................ 51COMPANY OVERVIEW .................................................................................................................................................................. 51KEY MILESTONES .......................................................................................................................................................................... 51PRODUCTS / TECHNOLOGIES ...................................................................................................................................................... 52RESEARCH STRATEGY ................................................................................................................................................................... 54AGREEMENTS ................................................................................................................................................................................. 55KEY FINANCIAL DATA .................................................................................................................................................................... 55ASSOCIATED COMPANIES ............................................................................................................................................................ 56

BAXA CORPORATION ...................................................................................................................................... 57KEY PERSONNEL ............................................................................................................................................................................ 57COMPANY OVERVIEW .................................................................................................................................................................. 57KEY MILESTONES .......................................................................................................................................................................... 57PRODUCTS / TECHNOLOGIES ...................................................................................................................................................... 58AGREEMENTS.................... ............................................................................................................................................................ 60KEY FINANCIAL DATA .................................................................................................................................................................... 60

BAXTER INTERNATIONAL INC .........................................................................................................................61KEY PERSONNEL ............................................................................................................................................................................ 61COMPANY OVERVIEW .................................................................................................................................................................. 61KEY MILESTONES .......................................................................................................................................................................... 61PRODUCTS / TECHNOLOGIES ...................................................................................................................................................... 62AGREEMENTS ................................................................................................................................................................................. 67KEY FINANCIAL DATA .................................................................................................................................................................... 68COMPETITION ................................................................................................................................................................................ 68

BIODELIVERY SCIENCES INTERNATIONAL .................................................................................................... 69KEY PERSONNEL ............................................................................................................................................................................ 69COMPANY OVERVIEW .................................................................................................................................................................. 69KEY MILESTONES .......................................................................................................................................................................... 69PRODUCTS / TECHNOLOGIES ...................................................................................................................................................... 69RESEARCH ACTIVITIES .................................................................................................................................................................. 72AGREEMENTS ................................................................................................................................................................................. 73KEY FINANCIAL DATA .................................................................................................................................................................... 73ASSOCIATED COMPANIES ............................................................................................................................................................ 73COMPETITION ................................................................................................................................................................................ 74

©Espicom Business Intelligence viiDecember 2010


BIOJECT MEDICAL TECHNOLOGIES INC .........................................................................................................75KEY PERSONNEL ............................................................................................................................................................................ 75COMPANY OVERVIEW .................................................................................................................................................................. 75KEY MILESTONE ............................................................................................................................................................................. 75PRODUCTS / TECHNOLOGIES ...................................................................................................................................................... 75RESEARCH ACTIVITIES .................................................................................................................................................................. 76AGREEMENTS ................................................................................................................................................................................. 78KEY FINANCIAL DATA .................................................................................................................................................................... 79COMPETITION ................................................................................................................................................................................ 79

BIOSANTE PHARMACEUTICALS INC ...............................................................................................................81KEY PERSONNEL ............................................................................................................................................................................ 81COMPANY OVERVIEW .................................................................................................................................................................. 81KEY MILESTONES .......................................................................................................................................................................... 81PRODUCTS / TECHNOLOGIES ...................................................................................................................................................... 82RESEARCH ACTIVITIES .................................................................................................................................................................. 84AGREEMENTS ................................................................................................................................................................................. 86KEY FINANCIAL DATA .................................................................................................................................................................... 87COMPETITION ................................................................................................................................................................................ 87

CALANDO PHARMACEUTICALS ..................................................................................................................... 89KEY PERSONNEL ............................................................................................................................................................................ 89COMPANY OVERVIEW .................................................................................................................................................................. 89KEY MILESTONES .......................................................................................................................................................................... 89PRODUCTS / TECHNOLOGIES ...................................................................................................................................................... 89RESEARCH ACTIVITIES .................................................................................................................................................................. 91AGREEMENTS ................................................................................................................................................................................. 91KEY FINANCIAL DATA .................................................................................................................................................................... 92

CAMURUS AB ................................................................................................................................................... 93KEY PERSONNEL ............................................................................................................................................................................ 93COMPANY OVERVIEW .................................................................................................................................................................. 93KEY MILESTONES .......................................................................................................................................................................... 93PRODUCTS / TECHNOLOGIES ...................................................................................................................................................... 93RESEARCH ACTIVITIES .................................................................................................................................................................. 96AGREEMENTS ................................................................................................................................................................................. 96KEY FINANCIAL DATA .................................................................................................................................................................... 97

CAREFUSION .................................................................................................................................................... 99KEY PERSONNEL ............................................................................................................................................................................ 99COMPANY OVERVIEW .................................................................................................................................................................. 99KEY MILESTONES .......................................................................................................................................................................... 99PRODUCTS ..................................................................................................................................................................................... 99AGREEMENTS ............................................................................................................................................................................... 101KEY FINANCIAL DATA .................................................................................................................................................................. 102COMPETITION .............................................................................................................................................................................. 102

CELATOR PHARMACEUTICALS INC .............................................................................................................. 103KEY PERSONNEL .......................................................................................................................................................................... 103COMPANY OVERVIEW ................................................................................................................................................................ 103KEY MILESTONES ........................................................................................................................................................................ 103PRODUCTS / TECHNOLOGIES ....................................................................................................................................................104R&D ACTIVITIES ........................................................................................................................................................................... 105AGREEMENTS ...............................................................................................................................................................................106KEY FINANCIAL DATA ..................................................................................................................................................................106

CELL THERAPEUTICS INC ...............................................................................................................................107

©Espicom Business Intelligence December 2010viii


KEY PERSONNEL .......................................................................................................................................................................... 107COMPANY OVERVIEW ................................................................................................................................................................ 107KEY MILESTONES ........................................................................................................................................................................ 107PRODUCTS / TECHNOLOGIES ....................................................................................................................................................108RESEARCH ACTIVITIES ................................................................................................................................................................108AGREEMENTS ................................................................................................................................................................................110KEY FINANCIAL DATA ...................................................................................................................................................................110

CEPHALON ......................................................................................................................................................111KEY PERSONNEL ...........................................................................................................................................................................111COMPANY OVERVIEW .................................................................................................................................................................111KEY MILESTONES .........................................................................................................................................................................111PRODUCTS ....................................................................................................................................................................................112R&D ACTIVITIES ............................................................................................................................................................................112AGREEMENTS ................................................................................................................................................................................114KEY FINANCIAL DATA ...................................................................................................................................................................116COMPETITION ...............................................................................................................................................................................116

CIPHER PHARMACEUTICALS .........................................................................................................................117KEY PERSONNEL ...........................................................................................................................................................................117COMPANY OVERVIEW .................................................................................................................................................................117KEY MILESTONES .........................................................................................................................................................................117PRODUCTS / TECHNOLOGIES .....................................................................................................................................................117R&D MILESTONES ........................................................................................................................................................................118AGREEMENTS ................................................................................................................................................................................119KEY FINANCIAL DATA ...................................................................................................................................................................119

COLUMBIA LABORATORIES INC ...................................................................................................................121KEY PERSONNEL .......................................................................................................................................................................... 121COMPANY OVERVIEW ................................................................................................................................................................ 121PRODUCTS / TECHNOLOGIES ................................................................................................................................................... 121RESEARCH ACTIVITIES ................................................................................................................................................................ 122AGREEMENTS ............................................................................................................................................................................... 123KEY FINANCIAL DATA .................................................................................................................................................................. 124COMPETITION .............................................................................................................................................................................. 125

CONSORT MEDICAL PLC ................................................................................................................................127KEY PERSONNEL .......................................................................................................................................................................... 127COMPANY OVERVIEW ................................................................................................................................................................ 127KEY MILESTONES ........................................................................................................................................................................ 127PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 127RESEARCH ACTIVITIES ................................................................................................................................................................ 129AGREEMENTS ............................................................................................................................................................................... 129KEY FINANCIAL DATA .................................................................................................................................................................. 130COMPETITION .............................................................................................................................................................................. 130

CORNERSTONE THERAPEUTICS....................................................................................................................131KEY PERSONNEL .......................................................................................................................................................................... 131COMPANY OVERVIEW ................................................................................................................................................................ 131KEY MILESTONES ........................................................................................................................................................................ 131PRODUCTS ................................................................................................................................................................................... 132RESEARCH ACTIVITIES ................................................................................................................................................................ 133AGREEMENTS ............................................................................................................................................................................... 134KEY FINANCIAL DATA .................................................................................................................................................................. 135ASSOCIATED COMPANIES .......................................................................................................................................................... 135

CPEX PHARMACEUTICALS INC ......................................................................................................................137

©Espicom Business Intelligence ixDecember 2010


KEY PERSONNEL .......................................................................................................................................................................... 137COMPANY OVERVIEW ................................................................................................................................................................ 137KEY MILESTONES ........................................................................................................................................................................ 137PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 137RESEARCH ACTIVITIES ................................................................................................................................................................ 138AGREEMENTS .............................................................................................................................................................................. 139KEY FINANCIAL DATA .................................................................................................................................................................. 139COMPETITION .............................................................................................................................................................................. 140

CYDEX PHARMACEUTICALS ..........................................................................................................................141KEY PERSONNEL .......................................................................................................................................................................... 141COMPANY OVERVIEW ................................................................................................................................................................ 141KEY MILESTONES ........................................................................................................................................................................ 141PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 141RESEARCH ACTIVITIES ................................................................................................................................................................144AGREEMENTS ............................................................................................................................................................................... 145KEY FINANCIAL DATA .................................................................................................................................................................. 145

DEBIOPHARM SA ............................................................................................................................................147KEY PERSONNEL .......................................................................................................................................................................... 147COMPANY OVERVIEW ................................................................................................................................................................ 147KEY MILESTONES ........................................................................................................................................................................ 147PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 148RESEARCH ACTIVITIES (as at August 2010) ............................................................................................................................. 149AGREEMENTS ............................................................................................................................................................................... 150KEY FINANCIAL DATA .................................................................................................................................................................. 151ASSOCIATED COMPANIES .......................................................................................................................................................... 151

DELCATH SYSTEMS INC .................................................................................................................................153KEY PERSONNEL .......................................................................................................................................................................... 153COMPANY OVERVIEW ................................................................................................................................................................ 153KEY MILESTONES ........................................................................................................................................................................ 153RESEARCH ACTIVITIES ................................................................................................................................................................ 154AGREEMENTS ............................................................................................................................................................................... 155KEY FINANCIAL DATA .................................................................................................................................................................. 155COMPETITION .............................................................................................................................................................................. 156

DEPOMED INC ................................................................................................................................................157KEY PERSONNEL .......................................................................................................................................................................... 157COMPANY OVERVIEW ................................................................................................................................................................ 157KEY MILESTONES ........................................................................................................................................................................ 157PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 157RESEARCH ACTIVITIES ................................................................................................................................................................ 158AGREEMENTS ............................................................................................................................................................................... 160KEY FINANCIAL DATA .................................................................................................................................................................. 161COMPETITION .............................................................................................................................................................................. 161

DURECT CORPORATION ............................................................................................................................... 163KEY PERSONNEL .......................................................................................................................................................................... 163COMPANY OVERVIEW ................................................................................................................................................................ 163KEY MILESTONES ........................................................................................................................................................................ 163PRODUCTS / TECHNOLOGIES ....................................................................................................................................................164RESEARCH ACTIVITIES .............................................................................................................................................................. 166AGREEMENTS ...............................................................................................................................................................................168KEY FINANCIAL DATA .................................................................................................................................................................. 169ASSOCIATED COMPANIES .......................................................................................................................................................... 169COMPETITION .............................................................................................................................................................................. 170

©Espicom Business Intelligence December 2010x


DUSA PHARMACEUTICALS INC .....................................................................................................................171KEY PERSONNEL .......................................................................................................................................................................... 171COMPANY OVERVIEW ................................................................................................................................................................ 171PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 171AGREEMENTS ............................................................................................................................................................................... 173KEY FINANCIAL DATA ...................................................................................................................................................................174COMPETITION ...............................................................................................................................................................................174

ECHO THERAPEUTICS ....................................................................................................................................175KEY PERSONNEL .......................................................................................................................................................................... 175COMPANY OVERVIEW ................................................................................................................................................................ 175PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 175RESEARCH ACTIVITIES ................................................................................................................................................................ 177AGREEMENTS ............................................................................................................................................................................... 178KEY FINANCIAL DATA .................................................................................................................................................................. 178COMPETITION .............................................................................................................................................................................. 179

ELAN CORPORATION .....................................................................................................................................181KEY PERSONNEL .......................................................................................................................................................................... 181COMPANY OVERVIEW ................................................................................................................................................................ 181KEY MILESTONES ........................................................................................................................................................................ 181PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 182RESEARCH ACTIVITIES ................................................................................................................................................................ 185AGREEMENTS ...............................................................................................................................................................................188KEY FINANCIAL DATA .................................................................................................................................................................. 189

ELITE PHARMACEUTICALS INC .....................................................................................................................191KEY PERSONNEL .......................................................................................................................................................................... 191COMPANY OVERVIEW ................................................................................................................................................................ 191KEY MILESTONES ........................................................................................................................................................................ 191PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 191RESEARCH ACTIVITIES ................................................................................................................................................................ 192AGREEMENTS ............................................................................................................................................................................... 192KEY FINANCIAL DATA .................................................................................................................................................................. 193COMPETITION .............................................................................................................................................................................. 193

EGEN INC .........................................................................................................................................................195KEY PERSONNEL .......................................................................................................................................................................... 195COMPANY OVERVIEW ................................................................................................................................................................ 195KEY MILESTONES ........................................................................................................................................................................ 195PRODUCTS/TECHNOLOGIES ..................................................................................................................................................... 195RESEARCH ACTIVITIES ................................................................................................................................................................ 196AGREEMENTS ............................................................................................................................................................................... 197KEY FINANCIAL DATA .................................................................................................................................................................. 198

EMISPHERE TECHNOLOGIES INC ................................................................................................................. 199KEY PERSONNEL .......................................................................................................................................................................... 199COMPANY OVERVIEW ................................................................................................................................................................ 199KEY MILESTONES ........................................................................................................................................................................ 199PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 199RESEARCH ACTIVITIES ................................................................................................................................................................203AGREEMENTS ...............................................................................................................................................................................203KEY FINANCIAL DATA ..................................................................................................................................................................204COMPETITION ..............................................................................................................................................................................205

ENCAP DRUG DELIVERY ............................................................................................................................... 207KEY PERSONNEL ..........................................................................................................................................................................207

©Espicom Business Intelligence xiDecember 2010


COMPANY OVERVIEW ................................................................................................................................................................207PRODUCTS / TECHNOLOGIES ....................................................................................................................................................207AGREEMENTS ...............................................................................................................................................................................208KEY FINANCIAL DATA ..................................................................................................................................................................209

ENDO PHARMACEUTICALS ...........................................................................................................................211KEY PERSONNEL ...........................................................................................................................................................................211COMPANY OVERVIEW .................................................................................................................................................................211KEY MILESTONES .........................................................................................................................................................................211TECHNOLOGIES/PRODUCTS...................................................................................................................................................... 212TECHNOLOGIES (Penwest) ........................................................................................................................................................ 213R&D MILESTONES (Endo) .......................................................................................................................................................... 216AGREEMENTS (Endo) .................................................................................................................................................................. 218AGREEMENTS (Penwest) ............................................................................................................................................................ 219COMPETITION .............................................................................................................................................................................. 219KEY FINANCIAL DATA ..................................................................................................................................................................220

ENDOCYTE ..................................................................................................................................................... 221KEY PERSONNEL .......................................................................................................................................................................... 221COMPANY OVERVIEW ................................................................................................................................................................ 221KEY MILESTONES ........................................................................................................................................................................ 221PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 221RESEARCH ACTIVITIES ................................................................................................................................................................222AGREEMENTS ...............................................................................................................................................................................223KEY FINANCIAL DATA ..................................................................................................................................................................223

ENZON INC ..................................................................................................................................................... 225KEY PERSONNEL ..........................................................................................................................................................................225COMPANY OVERVIEW ................................................................................................................................................................225KEY MILESTONES ........................................................................................................................................................................225PRODUCTS / TECHNOLOGIES ....................................................................................................................................................226RESEARCH ACTIVITIES ................................................................................................................................................................228KEY FINANCIAL DATA ..................................................................................................................................................................230COMPETITION ..............................................................................................................................................................................230

EPEIUS BIOTECHNOLOGIES INC .................................................................................................................. 231KEY PERSONNEL .......................................................................................................................................................................... 231COMPANY OVERVIEW ................................................................................................................................................................ 231KEY MILESTONES ........................................................................................................................................................................ 231PRODUCTS/TECHNOLOGIES .....................................................................................................................................................232RESEARCH ACTIVITIES ................................................................................................................................................................233KEY FINANCIAL DATA ..................................................................................................................................................................234COMPETITION ..............................................................................................................................................................................234

ETHYPHARM S/A ........................................................................................................................................... 237KEY PERSONNEL ..........................................................................................................................................................................237COMPANY OVERVIEW ................................................................................................................................................................237KEY MILESTONES ........................................................................................................................................................................237PRODUCTS / TECHNOLOGIES ....................................................................................................................................................237RESEARCH ACTIVITIES ................................................................................................................................................................240AGREEMENTS ...............................................................................................................................................................................240KEY FINANCIAL DATA .................................................................................................................................................................. 241

EURAND ......................................................................................................................................................... 243KEY PERSONNEL .......................................................................................................................................................................... 243COMPANY OVERVIEW ................................................................................................................................................................ 243KEY MILESTONES ........................................................................................................................................................................ 243

©Espicom Business Intelligence December 2010xii


PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 243RESEARCH ACTIVITIES ................................................................................................................................................................ 247AGREEMENTS ............................................................................................................................................................................... 247KEY FINANCIAL DATA ..................................................................................................................................................................248

FLAMEL TECHNOLOGIES INC ....................................................................................................................... 249KEY PERSONNEL ..........................................................................................................................................................................249COMPANY OVERVIEW ................................................................................................................................................................249KEY MILESTONES ........................................................................................................................................................................249PRODUCTS / TECHNOLOGIES ....................................................................................................................................................249R&D ACTIVITIES ...........................................................................................................................................................................252AGREEMENTS ...............................................................................................................................................................................252KEY FINANCIAL DATA ..................................................................................................................................................................253COMPETITION ..............................................................................................................................................................................253

FZIOMED INC ................................................................................................................................................. 255KEY PERSONNEL ..........................................................................................................................................................................255COMPANY OVERVIEW ................................................................................................................................................................255KEY MILESTONES ........................................................................................................................................................................255PRODUCTS / TECHNOLOGIES ....................................................................................................................................................255RESEARCH ACTIVITIES ................................................................................................................................................................257AGREEMENTS ...............................................................................................................................................................................258KEY FINANCIAL DATA ..................................................................................................................................................................258

GENEREX BIOTECHNOLOGY CORPORATION .............................................................................................. 259KEY PERSONNEL ..........................................................................................................................................................................259COMPANY OVERVIEW ................................................................................................................................................................259KEY MILESTONES ........................................................................................................................................................................259PRODUCTS / TECHNOLOGIES ....................................................................................................................................................260RESEARCH ACTIVITIES ................................................................................................................................................................ 261AGREEMENTS ...............................................................................................................................................................................264KEY FINANCIAL DATA ..................................................................................................................................................................265COMPETITION ..............................................................................................................................................................................265

GILEAD SCIENCES .......................................................................................................................................... 267KEY PERSONNEL .......................................................................................................................................................................... 267COMPANY OVERVIEW ................................................................................................................................................................ 267KEY MILESTONES ........................................................................................................................................................................ 267PRODUCTS / TECHNOLOGIES ....................................................................................................................................................268RESEARCH ACTIVITIES ................................................................................................................................................................ 271AGREEMENTS ............................................................................................................................................................................... 274KEY FINANCIAL DATA .................................................................................................................................................................. 275

HOSPIRA ........................................................................................................................................................ 277KEY PERSONNEL ..........................................................................................................................................................................277COMPANY OVERVIEW ................................................................................................................................................................277KEY MILESTONES ........................................................................................................................................................................277PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 278RESEARCH ACTIVITIES ................................................................................................................................................................ 281AGREEMENTS ...............................................................................................................................................................................282KEY FINANCIAL DATA ..................................................................................................................................................................283

IKANO THERAPEUTICS INC .......................................................................................................................... 285KEY PERSONNEL ..........................................................................................................................................................................285COMPANY OVERVIEW ................................................................................................................................................................285KEY MILESTONES ........................................................................................................................................................................285PRODUCTS / TECHNOLOGIES ....................................................................................................................................................285

©Espicom Business Intelligence xiiiDecember 2010


RESEARCH ACTIVITIES ................................................................................................................................................................286AGREEMENTS ...............................................................................................................................................................................287KEY FINANCIAL DATA ..................................................................................................................................................................287

IMMUNOGEN ............................................................................................................................................... 289KEY PERSONNEL ..........................................................................................................................................................................289COMPANY OVERVIEW ................................................................................................................................................................289KEY MILESTONES ........................................................................................................................................................................289PRODUCTS / TECHNOLOGIES ....................................................................................................................................................289RESEARCH ACTIVITIES ................................................................................................................................................................290AGREEMENTS ............................................................................................................................................................................... 292KEY FINANCIAL DATA ..................................................................................................................................................................293

IMPAX LABORATORIES ................................................................................................................................. 295KEY PERSONNEL ..........................................................................................................................................................................295COMPANY OVERVIEW ................................................................................................................................................................295KEY MILESTONES ........................................................................................................................................................................295PRODUCTS / TECHNOLOGIES ....................................................................................................................................................296RESEARCH ACTIVITIES ................................................................................................................................................................298AGREEMENTS ...............................................................................................................................................................................299KEY FINANCIAL DATA ..................................................................................................................................................................300COMPETITON ...............................................................................................................................................................................300

INNOCOLL TECHNOLOGIES .......................................................................................................................... 301KEY PERSONNEL .......................................................................................................................................................................... 301COMPANY OVERVIEW ................................................................................................................................................................ 301KEY MILESTONES ........................................................................................................................................................................ 301PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 301RESEARCH ACTIVITIES ................................................................................................................................................................303AGREEMENTS ...............................................................................................................................................................................305KEY FINANCIAL DATA ..................................................................................................................................................................305

INOVIO PHARMACEUTICALS ........................................................................................................................ 307KEY PERSONNEL ..........................................................................................................................................................................307COMPANY OVERVIEW ................................................................................................................................................................307KEY MILESTONES ........................................................................................................................................................................307TECHNOLOGIES / PRODUCTS ....................................................................................................................................................307RESEARCH ACTIVITIES ................................................................................................................................................................308AGREEMENTS ................................................................................................................................................................................311KEY FINANCIAL DATA .................................................................................................................................................................. 312KEY COMPETITORS ..................................................................................................................................................................... 312

INSITE VISION INC ..........................................................................................................................................313KEY PERSONNEL .......................................................................................................................................................................... 313COMPANY OVERVIEW ................................................................................................................................................................ 313KEY MILESTONES ........................................................................................................................................................................ 313PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 313RESEARCH ACTIVITIES ................................................................................................................................................................ 315AGREEMENTS ............................................................................................................................................................................... 316KEY FINANCIAL DATA .................................................................................................................................................................. 317COMPETITION .............................................................................................................................................................................. 317

INTELGENX CORPORATION ...........................................................................................................................319KEY PERSONNEL .......................................................................................................................................................................... 319COMPANY OVERVIEW ................................................................................................................................................................ 319KEY MILESTONES ........................................................................................................................................................................ 319PRODUCTS / TECHNOLOGIES ....................................................................................................................................................320

©Espicom Business Intelligence December 2010xiv


RESEARCH ACTIVITIES ................................................................................................................................................................ 321AGREEMENTS ...............................................................................................................................................................................322KEY FINANCIAL DATA ..................................................................................................................................................................323COMPETITION ..............................................................................................................................................................................323

INTERCELL AG ................................................................................................................................................ 325KEY PERSONNEL ..........................................................................................................................................................................325COMPANY OVERVIEW ................................................................................................................................................................325KEY MILESTONES ........................................................................................................................................................................325PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 326RESEARCH ACTIVITIES ............................................................................................................................................................... 327AGREEMENTS ..............................................................................................................................................................................328KEY FINANCIAL DATA ..................................................................................................................................................................329COMPETITION ..............................................................................................................................................................................329

KV PHARMACEUTICAL COMPANY ................................................................................................................331KEY PERSONNEL .......................................................................................................................................................................... 331COMPANY OVERVIEW ................................................................................................................................................................ 331KEY MILESTONES ........................................................................................................................................................................ 331PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 332AGREEMENTS ............................................................................................................................................................................... 333KEY FINANCIAL DATA ..................................................................................................................................................................334COMPETITION ..............................................................................................................................................................................334

LABOPHARM INC........................................................................................................................................... 335KEY PERSONNEL .......................................................................................................................................................................... 335COMPANY OVERVIEW ................................................................................................................................................................ 335KEY MILESTONES ........................................................................................................................................................................ 335PRODUCTS / TECHNOLOGIES ....................................................................................................................................................336RESEARCH ACTIVITIES ................................................................................................................................................................338AGREEMENTS ............................................................................................................................................................................... 339KEY FINANCIAL DATA ..................................................................................................................................................................340ASSOCIATED COMPANIES ..........................................................................................................................................................340COMPETITION ..............................................................................................................................................................................340

LAVIPHARM GROUP ...................................................................................................................................... 341KEY PERSONNEL .......................................................................................................................................................................... 341COMPANY OVERVIEW ................................................................................................................................................................ 341KEY MILESTONES ........................................................................................................................................................................ 341PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 341AGREEMENTS ...............................................................................................................................................................................343KEY FINANCIAL DATA ..................................................................................................................................................................344

LIGHT SCIENCES ONCOLOGY ....................................................................................................................... 345KEY PERSONNEL ..........................................................................................................................................................................345COMPANY OVERVIEW ................................................................................................................................................................345PRODUCTS / TECHNOLOGIES ....................................................................................................................................................345RESEARCH ACTIVITIES ................................................................................................................................................................346AGREEMENTS ...............................................................................................................................................................................347KEY FINANCIAL DATA ..................................................................................................................................................................347

MANNKIND CORPORATION ......................................................................................................................... 349KEY PERSONNEL ..........................................................................................................................................................................349COMPANY OVERVIEW ................................................................................................................................................................349KEY MILESTONES ........................................................................................................................................................................349PRODUCTS / TECHNOLOGIES ....................................................................................................................................................349RESEARCH ACTIVITIES ................................................................................................................................................................ 351

©Espicom Business Intelligence xvDecember 2010


AGREEMENTS ............................................................................................................................................................................... 352KEY FINANCIAL DATA .................................................................................................................................................................. 353COMPETITION .............................................................................................................................................................................. 353

MARINA BIOTECH ......................................................................................................................................... 355KEY PERSONNEL .......................................................................................................................................................................... 355COMPANY OVERVIEW ................................................................................................................................................................ 355 KEY MILESTONES ........................................................................................................................................................................ 355PRODUCTS / TECHNOLOGIES ....................................................................................................................................................356RESEARCH ACTIVITIES ................................................................................................................................................................ 357AGREEMENTS ............................................................................................................................................................................... 359KEY FINANCIAL DATA ..................................................................................................................................................................360COMPETITION ..............................................................................................................................................................................360

MAXCYTE INC .................................................................................................................................................361KEY PERSONNEL .......................................................................................................................................................................... 361COMPANY OVERVIEW ................................................................................................................................................................ 361PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 361AGREEMENTS ...............................................................................................................................................................................363KEY FINANCIAL DATA ..................................................................................................................................................................363

MEDIMMUNE INC .......................................................................................................................................... 365KEY PERSONNEL ..........................................................................................................................................................................365COMPANY OVERVIEW ................................................................................................................................................................365KEY MILESTONES ........................................................................................................................................................................365PRODUCTS / TECHNOLOGIES ....................................................................................................................................................366RESEARCH ACTIVITIES ................................................................................................................................................................ 367AGREEMENTS ...............................................................................................................................................................................368KEY FINANCIAL DATA ..................................................................................................................................................................369COMPETITION ..............................................................................................................................................................................369

MILESTONE SCIENTIFIC ................................................................................................................................ 371KEY PERSONNEL .......................................................................................................................................................................... 371COMPANY BACKGROUND .......................................................................................................................................................... 371KEY MILESTONES ........................................................................................................................................................................ 371PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 371AGREEMENTS ............................................................................................................................................................................... 373KEY FINANCIAL DATA .................................................................................................................................................................. 374COMPETITION .............................................................................................................................................................................. 374

MOOG MEDICAL DEVICES ............................................................................................................................375KEY PERSONNEL .......................................................................................................................................................................... 375COMPANY OVERVIEW ................................................................................................................................................................ 375KEY MILESTONES ........................................................................................................................................................................ 375PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 375AGREEMENTS ............................................................................................................................................................................... 376KEY FINANCIAL DATA .................................................................................................................................................................. 377

NANOBIOTIX .................................................................................................................................................. 379KEY PERSONNEL .......................................................................................................................................................................... 379COMPANY OVERVIEW ................................................................................................................................................................ 379PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 379RESEARCH ACTIVITIES ................................................................................................................................................................380AGREEMENTS ...............................................................................................................................................................................380KEY FINANCIAL DATA ..................................................................................................................................................................380

NANOMATERIALS TECHNOLOGY ................................................................................................................ 381

©Espicom Business Intelligence December 2010xvi


KEY PERSONNEL .......................................................................................................................................................................... 381COMPANY OVERVIEW ................................................................................................................................................................ 381KEY MILESTONES ........................................................................................................................................................................ 381PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 381KEY FINANCIAL DATA ..................................................................................................................................................................382

NANOBIO CORPORATION ............................................................................................................................. 383KEY PERSONNEL ..........................................................................................................................................................................383COMPANY OVERVIEW ................................................................................................................................................................383KEY MILESTONES ........................................................................................................................................................................383PRODUCTS / TECHNOLOGIES ....................................................................................................................................................383RESEARCH ACTIVITIES ................................................................................................................................................................384AGREEMENTS ...............................................................................................................................................................................386KEY FINANCIAL DATA ..................................................................................................................................................................386

NANOBIOMAGNETICS .................................................................................................................................. 387KEY PERSONNEL ..........................................................................................................................................................................387COMPANY OVERVIEW ................................................................................................................................................................387PRODUCTS / TECHNOLOGIES ....................................................................................................................................................387AGREEMENTS ...............................................................................................................................................................................388KEY FINANCIAL DATA ..................................................................................................................................................................388ASSOCIATED COMPANIES ..........................................................................................................................................................388

NANOCARRIER .............................................................................................................................................. 389KEY PERSONNEL ..........................................................................................................................................................................389COMPANY OVERVIEW ................................................................................................................................................................389PRODUCTS / TECHNOLOGIES ....................................................................................................................................................389RESEARCH ACTIVITIES ................................................................................................................................................................390AGREEMENTS ............................................................................................................................................................................... 391KEY FINANCIAL DATA .................................................................................................................................................................. 392

NANOTHERAPEUTICS INC ........................................................................................................................... 393KEY PERSONNEL .......................................................................................................................................................................... 393COMPANY OVERVIEW ................................................................................................................................................................ 393KEY MILESTONES ........................................................................................................................................................................ 393PRODUCTS / TECHNOLOGIES ....................................................................................................................................................394RESEARCH ACTIVITIES ................................................................................................................................................................ 397AGREEMENTS ...............................................................................................................................................................................398KEY FINANCIAL DATA ..................................................................................................................................................................398

NANOVENTURES AUSTRALIA ...................................................................................................................... 399KEY PERSONNEL ..........................................................................................................................................................................399COMPANY OVERVIEW ................................................................................................................................................................399KEY MILESTONES ........................................................................................................................................................................399PRODUCTS / TECHNOLOGIES ....................................................................................................................................................399RESEARCH ACTIVITIES ................................................................................................................................................................400AGREEMENTS ...............................................................................................................................................................................400KEY FINANCIAL DATA ..................................................................................................................................................................400ASSOCIATED ACTIVITIES ............................................................................................................................................................400

NEKTAR THERAPEUTICS .............................................................................................................................. 403KEY PERSONNEL ..........................................................................................................................................................................403COMPANY OVERVIEW ................................................................................................................................................................403KEY MILESTONES ........................................................................................................................................................................403PRODUCTS / TECHNOLOGIES ....................................................................................................................................................403RESEARCH ACTIVITIES ................................................................................................................................................................405AGREEMENTS ...............................................................................................................................................................................408

©Espicom Business Intelligence xviiDecember 2010


KEY FINANCIAL DATA ..................................................................................................................................................................409ASSOCIATED COMPANIES ..........................................................................................................................................................409COMPETITION ..............................................................................................................................................................................409

NEOPHARM INC ..............................................................................................................................................411KEY PERSONNEL ...........................................................................................................................................................................411COMPANY OVERVIEW .................................................................................................................................................................411KEY MILESTONES .........................................................................................................................................................................411PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 412AGREEMENTS ............................................................................................................................................................................... 414KEY FINANCIAL DATA .................................................................................................................................................................. 415

NEUROTECH ...................................................................................................................................................417KEY PERSONNEL .......................................................................................................................................................................... 417COMPANY OVERVIEW ................................................................................................................................................................ 417KEY MILESTONES ........................................................................................................................................................................ 417PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 417RESEARCH ACTIVITIES ................................................................................................................................................................ 419AGREEMENTS ............................................................................................................................................................................... 419KEY FINANCIAL DATA .................................................................................................................................................................. 420ASSOCIATED COMPANIES .......................................................................................................................................................... 420

NOVADEL PHARMA ....................................................................................................................................... 421KEY PERSONNEL .......................................................................................................................................................................... 421COMPANY OVERVIEW ................................................................................................................................................................ 421KEY MILESTONES ........................................................................................................................................................................ 421PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 421RESEARCH ACTIVITIES ................................................................................................................................................................422AGREEMENTS ............................................................................................................................................................................... 424KEY FINANCIAL DATA ..................................................................................................................................................................425COMPETITION ..............................................................................................................................................................................425

NOVAGALI PHARMA ..................................................................................................................................... 427KEY PERSONNEL .......................................................................................................................................................................... 427COMPANY OVERVIEW ................................................................................................................................................................ 427KEY MILESTONES ........................................................................................................................................................................ 427PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 427RESEARCH ACTIVITIES ................................................................................................................................................................428AGREEMENTS ...............................................................................................................................................................................430KEY FINANCIAL DATA ..................................................................................................................................................................430

NOVAVAX ...................................................................................................................................................... 431KEY PERSONNEL .......................................................................................................................................................................... 431COMPANY OVERVIEW ................................................................................................................................................................ 431KEY MILESTONES ........................................................................................................................................................................ 431PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 431RESEARCH ACTIVITIES ................................................................................................................................................................ 432AGREEMENTS ...............................................................................................................................................................................436KEY FINANCIAL DATA .................................................................................................................................................................. 437COMPETITION .............................................................................................................................................................................. 437

NOVEN PHARMACEUTICALS ........................................................................................................................ 439KEY PERSONNEL ..........................................................................................................................................................................439COMPANY OVERVIEW ................................................................................................................................................................439KEY MILESTONES ........................................................................................................................................................................439PRODUCTS / TECHNOLOGIES ....................................................................................................................................................439RESEARCH ACTIVITIES ................................................................................................................................................................441

©Espicom Business Intelligence December 2010xviii


AGREEMENTS ...............................................................................................................................................................................441KEY FINANCIAL DATA ..................................................................................................................................................................442COMPETITION ..............................................................................................................................................................................442

OAKWOOD LABORATORIES LLC .................................................................................................................. 443KEY PERSONNEL ..........................................................................................................................................................................443COMPANY OVERVIEW ................................................................................................................................................................443KEY MILESTONES ........................................................................................................................................................................443PRODUCTS / TECHNOLOGIES ....................................................................................................................................................443RESEARCH ACTIVITIES ................................................................................................................................................................444AGREEMENTS ...............................................................................................................................................................................444KEY FINANCIAL DATA ..................................................................................................................................................................444

OCTOPLUS...................................................................................................................................................... 445KEY PERSONNEL ..........................................................................................................................................................................445COMPANY OVERVIEW ................................................................................................................................................................445KEY MILESTONES ........................................................................................................................................................................445PRODUCTS / TECHNOLOGIES ....................................................................................................................................................445AGREEMENTS ...............................................................................................................................................................................448KEY FINANCIAL DATA ..................................................................................................................................................................449

OREXO ............................................................................................................................................................ 451KEY PERSONNEL .......................................................................................................................................................................... 451COMPANY OVERVIEW ................................................................................................................................................................ 451KEY MILESTONES ........................................................................................................................................................................ 451PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 452RESEARCH ACTIVITIES ................................................................................................................................................................454AGREEMENTS ...............................................................................................................................................................................456KEY FINANCIAL DATA ..................................................................................................................................................................458COMPETITION .............................................................................................................................................................................458

OTSUKA HOLDINGS ...................................................................................................................................... 459KEY PERSONNEL .......................................................................................................................................................................... 459COMPANY OVERVIEW ................................................................................................................................................................ 459KEY MILESTONES ........................................................................................................................................................................ 459PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 459RESEARCH ACTIVITIES ................................................................................................................................................................464AGREEMENTS ..............................................................................................................................................................................464KEY FINANCIAL DATA ..................................................................................................................................................................466

PACIRA PHARMACEUTICALS INC ................................................................................................................. 467KEY PERSONNEL ..........................................................................................................................................................................467COMPANY OVERVIEW ................................................................................................................................................................467KEY MILESTONES ........................................................................................................................................................................467PRODUCTS / TECHNOLOGIES ....................................................................................................................................................467RESEARCH ACTIVITIES ................................................................................................................................................................469AGREEMENTS ...............................................................................................................................................................................469KEY FINANCIAL DATA .................................................................................................................................................................. 470COMPETITION .............................................................................................................................................................................. 470

PCI BIOTECH .................................................................................................................................................. 471KEY PERSONNEL .......................................................................................................................................................................... 471COMPANY OVERVIEW ................................................................................................................................................................ 471KEY MILESTONES ........................................................................................................................................................................ 471PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 471RESEARCH ACTIVITIES ................................................................................................................................................................ 472AGREEMENTS ............................................................................................................................................................................... 473

©Espicom Business Intelligence xixDecember 2010


KEY FINANCIAL DATA .................................................................................................................................................................. 473

PHOSPHAGENICS LIMITED ............................................................................................................................475KEY PERSONNEL .......................................................................................................................................................................... 475COMPANY OVERVIEW ................................................................................................................................................................ 475KEY MILESTONES ........................................................................................................................................................................ 475TECHNOLOGIES / PRODUCTS .................................................................................................................................................... 475RESEARCH ACTIVITIES ................................................................................................................................................................ 478AGREEMENTS ............................................................................................................................................................................... 479FINANCIALS ..................................................................................................................................................................................480

PHOTOCURE ASA .......................................................................................................................................... 481KEY PERSONNEL ..........................................................................................................................................................................481COMPANY OVERVIEW ................................................................................................................................................................481KEY MILESTONES ........................................................................................................................................................................481PRODUCTS / TECHNOLOGIES ....................................................................................................................................................482RESEARCH ACTIVITIES ................................................................................................................................................................483AGREEMENTS ...............................................................................................................................................................................485KEY FINANCIAL DATA ..................................................................................................................................................................486ASSOCIATED COMPANIES ..........................................................................................................................................................486

POLYTHERICS LTD ......................................................................................................................................... 487KEY PERSONNEL ..........................................................................................................................................................................487COMPANY OVERVIEW ................................................................................................................................................................487PRODUCTS / TECHNOLOGIES ....................................................................................................................................................487PRODUCTS ...................................................................................................................................................................................488AGREEMENTS ...............................................................................................................................................................................488KEY FINANCIAL DATA ..................................................................................................................................................................489

PSIVIDA .......................................................................................................................................................... 491KEY PERSONNEL .......................................................................................................................................................................... 491COMPANY OVERVIEW ................................................................................................................................................................ 491KEY MILESTONES ........................................................................................................................................................................ 491TECHNOLOGIES / PRODUCTS .................................................................................................................................................... 491RESEARCH ACTIVITIES ................................................................................................................................................................ 492AGREEMENTS ...............................................................................................................................................................................494KEY FINANCIAL DATA ..................................................................................................................................................................496

QLT .................................................................................................................................................................. 497KEY PERSONNEL ..........................................................................................................................................................................497COMPANY OVERVIEW ................................................................................................................................................................497KEY MILESTONES ........................................................................................................................................................................497PRODUCTS / TECHNOLOGIES ....................................................................................................................................................497RESEARCH ACTIVITIES ................................................................................................................................................................498AGREEMENTS ...............................................................................................................................................................................500KEY FINANCIAL DATA .................................................................................................................................................................. 501COMPETITION .............................................................................................................................................................................. 501

QUEST PHARMATECH ................................................................................................................................... 503KEY PERSONNEL ..........................................................................................................................................................................503COMPANY OVERVIEW ................................................................................................................................................................503KEY MILESTONES ........................................................................................................................................................................503PRODUCTS / TECHNOLOGIES ....................................................................................................................................................503RESEARCH ACTIVITIES ................................................................................................................................................................504AGREEMENTS ...............................................................................................................................................................................504KEY FINANCIAL DATA ..................................................................................................................................................................505

©Espicom Business Intelligence December 2010xx


RAPTOR PHARMACEUTICALS ...................................................................................................................... 507KEY PERSONNEL ..........................................................................................................................................................................507COMPANY OVERVIEW ................................................................................................................................................................507KEY MILESTONES ........................................................................................................................................................................507PRODUCTS / TECHNOLOGIES ....................................................................................................................................................507RESEARCH ACTIVITIES ................................................................................................................................................................ 510AGREEMENTS ............................................................................................................................................................................... 512KEY FINANCIAL DATA .................................................................................................................................................................. 513COMPETITION .............................................................................................................................................................................. 513

RETRACTABLE TECHNOLOGIES INC .............................................................................................................515KEY PERSONNEL .......................................................................................................................................................................... 515COMPANY OVERVIEW ................................................................................................................................................................ 515PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 515KEY FINANCIAL DATA .................................................................................................................................................................. 516COMPETITION .............................................................................................................................................................................. 517

SAVARA PHARMACEUTICALS INC ................................................................................................................519KEY PERSONNEL .......................................................................................................................................................................... 519COMPANY OVERVIEW ................................................................................................................................................................ 519KEY MILESTONES ........................................................................................................................................................................ 519PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 519KEY FINANCIAL DATA ..................................................................................................................................................................520

SCOLR PHARMA INC.......................................................................................................................................521KEY PERSONNEL .......................................................................................................................................................................... 521COMPANY OVERVIEW ................................................................................................................................................................ 521PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 521RESEARCH ACTIVITIES ................................................................................................................................................................522AGREEMENTS ..............................................................................................................................................................................522KEY FINANCIAL DATA ..................................................................................................................................................................523COMPETITION ..............................................................................................................................................................................523

SEATTLE GENETICS ....................................................................................................................................... 525KEY PERSONNEL ..........................................................................................................................................................................525COMPANY OVERVIEW ................................................................................................................................................................525KEY MILESTONES ........................................................................................................................................................................525PRODUCTS / TECHNOLOGIES ....................................................................................................................................................525RESEARCH ACTIVITIES ................................................................................................................................................................ 526AGREEMENTS ...............................................................................................................................................................................528KEY FINANCIAL DATA ..................................................................................................................................................................529COMPETITION ..............................................................................................................................................................................529

SILENCE THERAPEUTICS................................................................................................................................531KEY PERSONNEL .......................................................................................................................................................................... 531COMPANY OVERVIEW ................................................................................................................................................................ 531KEY MILESTONES ........................................................................................................................................................................ 531PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 531RESEARCH ACTIVITIES ................................................................................................................................................................ 532AGREEMENTS ............................................................................................................................................................................... 532KEY FINANCIAL DATA .................................................................................................................................................................. 533

SKINVISIBLE INC ............................................................................................................................................ 535KEY PERSONNEL .......................................................................................................................................................................... 535COMPANY OVERVIEW ................................................................................................................................................................ 535KEY MILESTONES ........................................................................................................................................................................ 535PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 535

©Espicom Business Intelligence xxiDecember 2010


RESEARCH ACTIVITIES ................................................................................................................................................................536AGREEMENTS ............................................................................................................................................................................... 537KEY FINANCIAL DATA ..................................................................................................................................................................538COMPETITION ..............................................................................................................................................................................538

SKYEPHARMA PLC ........................................................................................................................................ 541KEY PERSONNEL .......................................................................................................................................................................... 541COMPANY OVERVIEW ................................................................................................................................................................ 541KEY MILESTONES ........................................................................................................................................................................ 541PRODUCTS / TECHNOLOGIES ....................................................................................................................................................542RESEARCH ACTIVITIES ................................................................................................................................................................547AGREEMENTS ...............................................................................................................................................................................547KEY FINANCIAL DATA ..................................................................................................................................................................548ASSOCIATED COMPANIES ..........................................................................................................................................................549COMPETITION ..............................................................................................................................................................................549

SOLIGENIX ......................................................................................................................................................551KEY PERSONNEL .......................................................................................................................................................................... 551COMPANY OVERVIEW ................................................................................................................................................................ 551KEY MILESTONES ........................................................................................................................................................................ 551PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 552RESEARCH ACTIVITIES ................................................................................................................................................................ 555AGREEMENTS ...............................................................................................................................................................................556KEY FINANCIAL DATA .................................................................................................................................................................. 557COMPETITION .............................................................................................................................................................................. 557

STARPHARMA ................................................................................................................................................ 559KEY PERSONNEL .......................................................................................................................................................................... 559COMPANY OVERVIEW ................................................................................................................................................................ 559KEY MILESTONES ........................................................................................................................................................................ 559PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 559RESEARCH ACTIVITIES ................................................................................................................................................................560AGREEMENTS ............................................................................................................................................................................... 561KEY FINANCIAL DATA ..................................................................................................................................................................562

SUPRATEK PHARMA INC .............................................................................................................................. 563KEY PERSONNEL ..........................................................................................................................................................................563COMPANY OVERVIEW ................................................................................................................................................................563KEY MILESTONES ........................................................................................................................................................................563PRODUCTS / TECHNOLOGIES ....................................................................................................................................................563RESEARCH ACTIVITIES ................................................................................................................................................................565KEY FINANCIAL DATA ..................................................................................................................................................................565

TEKMIRA PHARMACEUTICALS CORPORATION .......................................................................................... 567KEY PERSONNEL .......................................................................................................................................................................... 567COMPANY OVERVIEW ................................................................................................................................................................ 567KEY MILESTONES ........................................................................................................................................................................ 567PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 567RESEARCH ACTIVITIES ................................................................................................................................................................569AGREEMENTS ............................................................................................................................................................................... 571KEY FINANCIAL DATA ..................................................................................................................................................................573

TELESSO TECHNOLOGIES ..............................................................................................................................575KEY PERSONNEL .......................................................................................................................................................................... 575COMPANY OVERVIEW ................................................................................................................................................................ 575KEY MILESTONES ........................................................................................................................................................................ 575PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 575

©Espicom Business Intelligence December 2010xxii


RESEARCH ACTIVITIES ............................................................................................................................................................... 578AGREEMENTS ............................................................................................................................................................................... 578KEY FINANCIAL DATA .................................................................................................................................................................. 579ASSOCIATED COMPANIES .......................................................................................................................................................... 579

TRANSDEL PHARMACEUTICALS INC ........................................................................................................... 581KEY PERSONNEL .......................................................................................................................................................................... 581COMPANY OVERVIEW ................................................................................................................................................................ 581KEY MILESTONES ........................................................................................................................................................................ 581PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 581RESEARCH ACTIVITIES ................................................................................................................................................................582AGREEMENTS ...............................................................................................................................................................................583COMPETITION ..............................................................................................................................................................................584KEY FINANCIAL DATA ..................................................................................................................................................................584

TRANSPHARMA MEDICAL ............................................................................................................................ 585KEY PERSONNEL .........................................................................................................................................................................585COMPANY OVERVIEW ................................................................................................................................................................585KEY MILESTONES ........................................................................................................................................................................585PRODUCTS / TECHNOLOGIES ....................................................................................................................................................585RESEARCH ACTIVITIES ................................................................................................................................................................587AGREEMENTS ...............................................................................................................................................................................588KEY FINANCIAL DATA ..................................................................................................................................................................589

URIGEN PHARMACEUTICALS ....................................................................................................................... 591KEY PERSONNEL .......................................................................................................................................................................... 591COMPANY OVERVIEW ................................................................................................................................................................ 591KEY MILESTONES ........................................................................................................................................................................ 591PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 592RESEARCH ACTIVITIES ................................................................................................................................................................594AGREEMENTS ............................................................................................................................................................................... 595KEY FINANCIAL DATA .................................................................................................................................................................. 595ASSOCIATED COMPANIES .......................................................................................................................................................... 595COMPETITION ............................................................................................................................................................................. 595

VALEANT PHARMACEUTICALS .................................................................................................................... 597KEY PERSONNEL .......................................................................................................................................................................... 597COMPANY OVERVIEW ................................................................................................................................................................ 597KEY MILESTONES ........................................................................................................................................................................ 597PRODUCTS / TECHNOLOGIES (VALEANT) ...............................................................................................................................598PRODUCTS / TECHNOLOGIES (BIOVAIL) ..................................................................................................................................599RESEARCH ACTIVITIES (VALEANT) ............................................................................................................................................601AGREEMENTS ..............................................................................................................................................................................602KEY FINANCIAL DATA ..................................................................................................................................................................604ASSOCIATED COMPANIES ..........................................................................................................................................................605COMPETITION (BIOVAIL) ............................................................................................................................................................605

VECTURA LTD ................................................................................................................................................ 607KEY PERSONNEL ..........................................................................................................................................................................607COMPANY OVERVIEW ................................................................................................................................................................607KEY MILESTONES ........................................................................................................................................................................607PRODUCTS / TECHNOLOGIES ....................................................................................................................................................607RESEARCH ACTIVITIES ................................................................................................................................................................ 610AGREEMENTS ............................................................................................................................................................................... 612KEY FINANCIAL DATA .................................................................................................................................................................. 613ASSOCIATED COMPANIES .......................................................................................................................................................... 613

©Espicom Business Intelligence xxiiiDecember 2010


VICAL INC ........................................................................................................................................................615KEY PERSONNEL .......................................................................................................................................................................... 615COMPANY OVERVIEW ................................................................................................................................................................ 615KEY MILESTONES ........................................................................................................................................................................ 615PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 615RESEARCH ACTIVITIES ................................................................................................................................................................ 616AGREEMENTS ............................................................................................................................................................................... 619KEY FINANCIAL DATA ..................................................................................................................................................................620

VIVUS INC ....................................................................................................................................................... 621KEY PERSONNEL .......................................................................................................................................................................... 621COMPANY OVERVIEW ................................................................................................................................................................ 621KEY MILESTONES ........................................................................................................................................................................ 621PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 621RESEARCH ACTIVITIES ................................................................................................................................................................ 624AGREEMENTS ...............................................................................................................................................................................625KEY FINANCIAL DATA ..................................................................................................................................................................626COMPETITION ..............................................................................................................................................................................626

ZOGENIX INC .................................................................................................................................................. 627KEY PERSONNEL ..........................................................................................................................................................................627COMPANY OVERVIEW ................................................................................................................................................................627KEY MILESTONES ........................................................................................................................................................................627PRODUCTS / TECHNOLOGIES ....................................................................................................................................................627PRODUCTS ...................................................................................................................................................................................628RESEARCH ACTIVITIES ................................................................................................................................................................628AGREEMENTS ...............................................................................................................................................................................629KEY FINANCIAL DATA ..................................................................................................................................................................629

ZOSANO PHARMA ..........................................................................................................................................631KEY PERSONNEL .......................................................................................................................................................................... 631COMPANY OVERVIEW ................................................................................................................................................................ 631PRODUCTS / TECHNOLOGIES .................................................................................................................................................... 631RESEARCH ACTIVITIES ................................................................................................................................................................ 632KEY FINANCIAL DATA .................................................................................................................................................................. 632

Documents

Drug Delivery - FDAnews€¦ · List of companies in this report 3M DDS Abraxis BioScience Access Pharmaceuticals Inc Acrux Ltd Alkermes Inc Apricus Biosciences Aptar Group ... Vivus